HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.

AbstractPURPOSE:
Attempts to selectively initiate tumor cell death through inducible apoptotic pathways are increasingly being exploited as a potential anticancer strategy. Inhibition of NAD+ synthesis by a novel agent FK866 has been recently reported to induce apoptosis in human leukemia, hepatocarcinoma cells in vitro, and various types of tumor xenografts in vivo. In the present study, we used 1H-decoupled phosphorus (31P) magnetic resonance spectroscopy (MRS) to examine the metabolic changes associated with FK866 induced tumor cell death in a mouse mammary carcinoma.
EXPERIMENTAL DESIGN:
Induction of apoptosis in FK866-treated tumors was confirmed by histology and cytofluorometric analysis. FK866-induced changes in mammary carcinoma tumor metabolism in vivo were investigated using 1H-decoupled 31P MRS. To discern further the changes in metabolic profiles of tumors observed in vivo, high-resolution in vitro 1H-decoupled 31P MRS studies were carried out with perchloric acid extracts of mammary carcinoma tumors excised after similar treatments. In addition, the effects of FK866 on mammary carcinoma tumor growth and radiation sensitivity were studied.
RESULTS:
Treatment with FK866 induced a tumor growth delay and enhanced radiation sensitivity in mammary carcinoma tumors that was associated with significant increases in the 31P MR signal in the phosphomonoester region and a decrease in NAD+ levels, pH, and bioenergetic status. The 31P MRS of perchloric acid extracts of treated tumors identified the large unresolved signal in the phosphomonoester region as the resultant of resonances originating from intermediates of tumor glycolysis and guanylate synthesis in addition to alterations in pyridine nucleotide pools and phospholipid metabolism.
CONCLUSION:
The present results suggest that FK866 interferes with multiple biochemical pathways that contribute to the increased cell death (apoptosis) and subsequent radiation sensitivity observed in the mammary carcinoma that could be serially monitored by 31P MRS.
AuthorsManickam Muruganandham, Alan A Alfieri, Cornelia Matei, Yuchun Chen, George Sukenick, Isabel Schemainda, Max Hasmann, Leonard B Saltz, Jason A Koutcher
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 11 Issue 9 Pg. 3503-13 (May 01 2005) ISSN: 1078-0432 [Print] United States
PMID15867253 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Acrylamides
  • Annexin A5
  • Guanine Nucleotides
  • N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
  • Phospholipids
  • Piperidines
  • NAD
  • NADP
  • Pentosyltransferases
  • Nicotinamide Phosphoribosyltransferase
Topics
  • Acrylamides (pharmacology, therapeutic use)
  • Animals
  • Annexin A5 (metabolism)
  • Apoptosis (drug effects)
  • Cell Cycle (drug effects)
  • Glycolysis (drug effects)
  • Guanine Nucleotides (metabolism)
  • Hydrogen-Ion Concentration (drug effects)
  • Intracellular Membranes (drug effects, physiology)
  • Magnetic Resonance Spectroscopy (methods)
  • Male
  • Mammary Neoplasms, Experimental (metabolism, pathology, prevention & control)
  • Membrane Potentials (drug effects)
  • Mice
  • Mice, Inbred C3H
  • Mitochondria (drug effects, physiology)
  • Mitosis (drug effects)
  • NAD (metabolism)
  • NADP (metabolism)
  • Neoplasm Transplantation
  • Nicotinamide Phosphoribosyltransferase
  • Pentosyltransferases (antagonists & inhibitors)
  • Phospholipids (metabolism)
  • Piperidines (pharmacology, therapeutic use)
  • Protein Binding (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: